At-Home Alzheimer's Detection Service

About Neurogen Biomarking

Neurogen Biomarking, founded in 2018 and based in San Diego, is developing a direct-to-consumer diagnostic platform for the early detection of Alzheimer's disease. Its core offering is an integrated 'Memory Health ecosystem' that includes an at-home blood test kit, online cognitive screening, and personalized review and guidance from board-certified neurologists. The company is currently in a beta launch phase, positioning itself to capitalize on the growing demand for accessible, pre-symptomatic Alzheimer's testing enabled by recent advances in blood-based biomarkers. Neurogen's model bridges consumer diagnostics with clinical expertise, aiming to facilitate earlier intervention and personalized care planning.

Therapeutic Areas